With expert input from members of the U.S. Biovigilance Network, the Centers for Disease Control and Prevention developed the Hemovigilance Module of the National Healthcare Safety Network, or NHSN — a secure, voluntary, Internet-based surveillance system that monitors patient and health care personnel safety. Participating hospitals can use the module to monitor adverse events associated with blood transfusions. By enrolling in this system, facilities can report their data confidentially, which are then tracked at the local and national level. Aggregate data can be used to help hospitals benchmark their performance.
Participating facilities can join AABB's Transfusion Safety Group within the NHSN, giving them the benefit of further data analysis by AABB and recommendations for targeted interventions and best practices that can be implemented and tracked to improve the safety, quality and efficiency of patient care.
Click on a link below to learn how to join and use the module as well as understand the expected benefits.